• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于泊洛沙姆 F127 共聚物的新型透皮厚朴酚制剂。

A novel transdermal honokiol formulation based on Pluronic F127 copolymer.

机构信息

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, PR China.

出版信息

Drug Deliv. 2010 Apr;17(3):138-44. doi: 10.3109/10717541003604874.

DOI:10.3109/10717541003604874
PMID:20175649
Abstract

This paper developed a new hydrophobic honokiol transdermal delivery system. First, Honokiol was loaded into Pluronic F127 micelles by direct dissolution method assisted by ultrasound. Then the obtained honokiol-loaded F127 micelles were incorporated into thermosensitive F127 hydrogel, which made the composite system bioadhesive. The particle size, drug loading, and encapsulation efficiency were determined. The sol-gel transitions of the copolymer, honokiol release profile in vitro, and the permeation studies in vitro were studied in detail. The lower critical solution temperature (LCST) of the composite system decreases with increase in the mass of honokiol in the system. Honokiol could be sustained released from the system in vitro. In in vitro permeation studies, honokiol could be absorbed per cutem. The described drug delivery system might have great potential application for transdermal delivery of hydrophobic drugs such as honokiol.

摘要

本文研制了一种新的厚朴酚透皮给药系统。首先,采用超声辅助直接溶解法将厚朴酚载入 Pluronic F127 胶束中。然后将所得的载厚朴酚 F127 胶束掺入温敏 F127 水凝胶中,使复合体系具有生物黏附性。测定了粒径、载药量和包封效率。详细研究了共聚物的溶胶-凝胶转变、体外厚朴酚释放曲线和体外渗透研究。复合体系的低临界溶液温度(LCST)随体系中厚朴酚质量的增加而降低。厚朴酚可以从体系中进行持续释放。在体外渗透研究中,厚朴酚可以经皮吸收。所述药物传递系统可能在透皮传递疏水性药物如厚朴酚方面具有很大的应用潜力。

相似文献

1
A novel transdermal honokiol formulation based on Pluronic F127 copolymer.基于泊洛沙姆 F127 共聚物的新型透皮厚朴酚制剂。
Drug Deliv. 2010 Apr;17(3):138-44. doi: 10.3109/10717541003604874.
2
A novel injectable local hydrophobic drug delivery system: Biodegradable nanoparticles in thermo-sensitive hydrogel.一种新型可注射局部疏水药物递送系统:热敏水凝胶中的可生物降解纳米颗粒。
Int J Pharm. 2008 Jul 9;359(1-2):228-33. doi: 10.1016/j.ijpharm.2008.03.023. Epub 2008 Mar 25.
3
Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.用于厚朴酚递送的新型复合药物递送系统:热敏性聚(乙二醇)-聚(ε-己内酯)-聚(乙二醇)水凝胶中的自组装聚(乙二醇)-聚(ε-己内酯)-聚(乙二醇)胶束
J Phys Chem B. 2009 Jul 30;113(30):10183-8. doi: 10.1021/jp902697d.
4
Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.基于聚(ε-己内酯)-聚(乙二醇)-聚(ε-己内酯)共聚物的自组装厚朴酚载药胶束。
Int J Pharm. 2009 Mar 18;369(1-2):170-5. doi: 10.1016/j.ijpharm.2008.10.027. Epub 2008 Nov 5.
5
Sirolimus-loaded polymeric micelles with honokiol for oral delivery.负载西罗莫司并含有厚朴酚的聚合物胶束用于口服给药。
J Pharm Pharmacol. 2015 Dec;67(12):1663-72. doi: 10.1111/jphp.12482. Epub 2015 Oct 10.
6
Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization.可生物降解的自组装 PEG-PCL-PEG 胶束用于递送疏水性厚朴酚:I. 制备与表征。
Nanotechnology. 2010 May 28;21(21):215103. doi: 10.1088/0957-4484/21/21/215103. Epub 2010 Apr 30.
7
Synthesis, structural and in vitro studies of well-dispersed monomethoxy-poly(ethylene glycol)-honokiol conjugate micelles.单甲氧基聚乙二醇-厚朴酚偶联胶束的合成、结构及体外研究。
Biomed Mater. 2010 Dec;5(6):065006. doi: 10.1088/1748-6041/5/6/065006. Epub 2010 Oct 22.
8
Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro.体外递送和厚朴酚用 MPEG-PLA 纳米粒的制备。
Int J Pharm. 2010 Feb 15;386(1-2):262-7. doi: 10.1016/j.ijpharm.2009.11.014. Epub 2009 Nov 20.
9
Oligochitosan-pluronic 127 conjugate for delivery of honokiol.低聚壳聚糖-泊洛沙姆 127 缀合物递送和厚朴酚。
Artif Cells Nanomed Biotechnol. 2018;46(sup1):740-750. doi: 10.1080/21691401.2018.1434785. Epub 2018 Feb 5.
10
Enhancement of oral bioavailability of magnolol by encapsulation in mixed micelles containing pluronic F127 and L61.用含有普朗尼克 F127 和 L61 的混合胶束包封来提高厚朴酚的口服生物利用度。
J Pharm Pharmacol. 2018 Apr;70(4):498-506. doi: 10.1111/jphp.12887. Epub 2018 Feb 12.

引用本文的文献

1
Nanotechnology-Based Drug Delivery Systems for Honokiol: Enhancing Therapeutic Potential and Overcoming Limitations.基于纳米技术的霍诺酚药物传递系统:提高治疗潜力和克服局限性。
Int J Nanomedicine. 2023 Nov 13;18:6639-6665. doi: 10.2147/IJN.S431409. eCollection 2023.
2
The application prospects of honokiol in dermatology.霍诺非醇在皮肤科的应用前景。
Dermatol Ther. 2022 Aug;35(8):e15658. doi: 10.1111/dth.15658. Epub 2022 Jun 28.
3
Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
厚朴酚纳米胶束制剂提高了三阴性乳腺癌(TNBC)的口服生物利用度和抗癌效果。
Colloids Surf B Biointerfaces. 2017 May 1;153:208-219. doi: 10.1016/j.colsurfb.2017.01.038. Epub 2017 Jan 23.
4
Neuro-modulating effects of honokiol: a review.厚朴酚的神经调节作用:综述。
Front Neurol. 2013 Sep 11;4:130. doi: 10.3389/fneur.2013.00130. eCollection 2013.